Is Herd Immunity Against SARS-CoV-2 a Silver Lining?

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 11; p. 586781
Main Authors Vignesh, Ramachandran, Shankar, Esaki M., Velu, Vijayakumar, Thyagarajan, Sadras Panchatcharam
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 30.09.2020
Subjects
Betacoronavirus - immunology
coronavirus disease 2019
Coronavirus Infections - immunology
Coronavirus Infections - prevention & control
COVID-19
COVID-19 Vaccines
herd immunity
Humans
Immunity, Herd - immunology
Immunology
Pandemics - prevention & control
Pneumonia, Viral - immunology
Pneumonia, Viral - prevention & control
SARS-CoV-2
seroprevalence
severe acute respiratory syndrome coronavirus-2
vaccines
Viral Vaccines - immunology
herd immunity
seroprevalence
severe acute respiratory syndrome coronavirus-2
vaccines
coronavirus disease 2019
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Amit Awasthi, Translational Health Science and Technology Institute (THSTI), India
This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology
Edited by: Francesca Chiodi, Karolinska Institutet (KI), Sweden
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2020.586781